Related Experiment Video
Updated: Jul 30, 2026

Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse
Published on: March 9, 2022
[Pharmacokinetics of lidocaine in perfused rat liver]
E Katagiri1, M Sakai, H Horikawa
1Department of Anesthesia, Yamagata University School of Medicine.
Abstract:
Lidocaine pharmacokinetics were studied using perfused rat livers under several conditions. 1) In the low perfusion group (perfusion rate = 1/2 of control group), the elimination rate constant and clearance of lidocaine in the first phase were reduced, but in the second phase, metabolism of lidocaine was more active than in other groups. 2) High albumin concentration in the perfusate did not significantly affect lidocaine metabolism. 3) Low pH of the perfusate (pH = 7.10) did not affect the metabolism of lidocaine. 4) Acute and chronic liver damage inhibited the lidocaine metabolism, which may be due to decreases in viable hepatocytes, effective hepatic blood flow and mitochondrial P-450. 5) Halothane in the concentration of 2.5% reduced the lidocaine metabolism. This was probably due to inhibition of hepatocyte activity by halothane because increases in GOT, LDH and lactate in the perfusate and a decrease in the O2 consumption by the rat liver were observed.
Related Concept Videos
Local Anesthetics: Pharmacokinetics
Factors Affecting Drug Distribution: Organ Perfusion Rate
Perfusion rate-limited distribution relies on the...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

